$NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Healthcare
Sector
Medical - Devices
Industry
Marvin L. Slosman
CEO
85
Employees
$1.03
Current Price
$73.30M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $23,005.78 | 22,778 | ||
| 2 weeks | Buys | 2 | 4 | $54,425.00 | 46,000 | 2.37:1 |
| Sells | 1 | 1 | $23,005.78 | 22,778 | ||
| 1 month | Buys | 4 | 10 | $348,422.40 | 298,771 | 15.14:1 |
| Sells | 1 | 1 | $23,005.78 | 22,778 | ||
| 2 months | Buys | 4 | 10 | $348,422.40 | 298,771 | 15.14:1 |
| Sells | 1 | 1 | $23,005.78 | 22,778 | ||
| 3 months | Buys | 4 | 10 | $348,422.40 | 298,771 | 15.14:1 |
| Sells | 1 | 1 | $23,005.78 | 22,778 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 19, 2026 | Gleason Shane Thomas Chief Commercial Officer | Sale | 22,778 | $1.01 | $23,005.78 | View Details |
| May 13, 2026 | Stuka Paul Director | Purchase | 10,000 | $1.16 | $11,575.00 | View Details |
| May 14, 2026 | Stuka Paul Director | Purchase | 5,000 | $1.15 | $5,750.00 | View Details |
| May 12, 2026 | Slosman Marvin Director | Purchase | 21,000 | $1.20 | $25,200.00 | View Details |
| May 11, 2026 | Stuka Paul Director | Purchase | 10,000 | $1.19 | $11,900.00 | View Details |
| May 8, 2026 | Stuka Paul Director | Purchase | 65,626 | $1.16 | $76,126.16 | View Details |
| May 7, 2026 | Ward Scott R. Director | Purchase | 73,255 | $1.15 | $84,243.25 | View Details |
| May 6, 2026 | Ward Scott R. Director | Purchase | 15,995 | $1.15 | $18,394.25 | View Details |
| May 6, 2026 | Stuka Paul Director | Purchase | 1,517 | $1.12 | $1,699.04 | View Details |
| May 7, 2026 | Stuka Paul Director | Purchase | 6,378 | $1.15 | $7,334.70 | View Details |
| May 7, 2026 | ROUBIN GARY S Director | Purchase | 90,000 | $1.18 | $106,200.00 | View Details |
22 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.19
Actual-$0.14
Beat
Revenue
Estimated$2.38M
Actual$3.15M
Beat
EPS
Estimated-$0.22
ActualN/A
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ create a free account to see 12 months of history